TVM Life Science Management GmbH

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024

TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE

TVM CAPITAL LIFE SCIENCE INVESTIERT 8 MILLIONEN EURO IN MYO, UM DIE ALTENPFLEGE ZU REVOLUTIONIEREN

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.